Mango Five Family’s Gilead Sciences GILD Stock Holding History

Mango Five Family’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,400	Closed	-$113K	–	77
2023 Q4	$113K	Buy	+1,400	New	+$109K	0.04%	59

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mango Five Family's GILD Position: Q1 2024 in Review

Mango Five Family sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 1,400 shares — an estimated $113K sold.

Mango Five Family first reported a position in GILD in Q4 2023 and held it in 1 quarter. The position peaked at $113K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

Mango Five Family reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
Mango Five Family sold 1,400 Gilead Sciences shares in Q1 2024, an estimated $113K.
Mango Five Family first reported a position in Gilead Sciences in Q4 2023 and held it in 1 quarter.
Mango Five Family's Gilead Sciences position peaked at $113K in Q4 2023.
1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Mango Five Family's 13F filing for Q1 2024, filed 16 May 2024.